全文获取类型
收费全文 | 4267273篇 |
免费 | 341883篇 |
国内免费 | 14456篇 |
专业分类
耳鼻咽喉 | 60103篇 |
儿科学 | 136254篇 |
妇产科学 | 110995篇 |
基础医学 | 651675篇 |
口腔科学 | 114139篇 |
临床医学 | 392688篇 |
内科学 | 772888篇 |
皮肤病学 | 109826篇 |
神经病学 | 355630篇 |
特种医学 | 165607篇 |
外国民族医学 | 503篇 |
外科学 | 661746篇 |
综合类 | 119313篇 |
现状与发展 | 91篇 |
一般理论 | 2562篇 |
预防医学 | 354642篇 |
眼科学 | 100403篇 |
药学 | 294635篇 |
26篇 | |
中国医学 | 11300篇 |
肿瘤学 | 208586篇 |
出版年
2021年 | 56658篇 |
2020年 | 37765篇 |
2019年 | 59027篇 |
2018年 | 76625篇 |
2017年 | 59287篇 |
2016年 | 65604篇 |
2015年 | 78543篇 |
2014年 | 115531篇 |
2013年 | 180506篇 |
2012年 | 122441篇 |
2011年 | 127948篇 |
2010年 | 129322篇 |
2009年 | 131991篇 |
2008年 | 114325篇 |
2007年 | 120951篇 |
2006年 | 130544篇 |
2005年 | 124893篇 |
2004年 | 124778篇 |
2003年 | 114944篇 |
2002年 | 104162篇 |
2001年 | 150872篇 |
2000年 | 145363篇 |
1999年 | 135225篇 |
1998年 | 71416篇 |
1997年 | 67336篇 |
1996年 | 65228篇 |
1995年 | 60441篇 |
1994年 | 54224篇 |
1993年 | 50355篇 |
1992年 | 96322篇 |
1991年 | 93037篇 |
1990年 | 89336篇 |
1989年 | 87124篇 |
1988年 | 80271篇 |
1987年 | 78738篇 |
1986年 | 74091篇 |
1985年 | 73131篇 |
1984年 | 61756篇 |
1983年 | 55503篇 |
1982年 | 46088篇 |
1981年 | 43156篇 |
1980年 | 40548篇 |
1979年 | 53129篇 |
1978年 | 44061篇 |
1977年 | 38922篇 |
1976年 | 36291篇 |
1975年 | 36289篇 |
1974年 | 39431篇 |
1973年 | 37650篇 |
1972年 | 35269篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
941.
弹性绷带在乳腺癌术后应用的效果观察 总被引:1,自引:0,他引:1
目的 观察弹性绷带在乳腺癌术后应用效果。方法 4 8例乳腺癌根治术后应用弹性绷带包扎为实验组 ,4 5例用普通宽绷带包扎为对照组。然后 ,对两组患者术后并发症进行观察。结果 实验组患者的并发症明显低于对照组 ,两组比较有显著性差异 ,P <0 .0 5。结论 应用弹性绷带包扎 ,能明显减少并发症的发生 ,促进切口愈合 ,使患者术后术侧上肢功能锻炼可以提早进行。 相似文献
942.
Asawanonda P. Chingchai A. Torranin P. 《世界核心医学期刊文摘》2006,2(3):25-25
目的:确定UVB靶向光疗治疗局限性银屑病是否安全有效及是否存在量效关系。设计:随机、对评估者设盲对照研究。机构:泰国曼谷大学医院皮肤病门诊。患者:14例稳定性局限性斑块型银屑病患者。干预:依据预定的最小红斑量(M EDs),随机给予患者不同通量的UVB靶向光线治疗,3次/周。在4 相似文献
943.
Gregory Guldner MD MS Jason Schultz BS Perry Sexton MD Corwyn Fortner BS Mark Richmond MD 《Academic emergency medicine》2003,10(2):134-139
OBJECTIVES: Physicians commonly use etomidate for adult rapid-sequence intubation (RSI), but the manufacturer does not recommend its use for children under 10 years of age due to a lack of data. The authors present their experience with etomidate for pediatric RSI in order to further develop its risk-benefit profile in this age group. METHODS: Trained abstractors reviewed the medical records for all children under 10 years old who received etomidate for RSI between July 1996 and April 2001. RESULTS: 105 children, with an average age of 3 (+/-2.9) years, received a median dose of 0.32 (+/-0.12) mg/kg of etomidate. The systolic blood pressure increased an average of 4 mm Hg (95% CI = -3.3 to 9.2); the diastolic blood pressure increased 7 mm Hg (95% CI = -3.1 to 11) within 10 minutes of receiving etomidate. The heart rate increased an average of 10 beats/min (95% CI = 4.0 to 17.4). Complications included three patients who vomited within 10 minutes of etomidate administration. There were no cases of documented myoclonus, status epilepticus, or new-onset seizures. Thirty-eight patients received corticosteroids during the hospital course, none for suspected adrenal insufficiency. Three patients died, all from severe brain injury. CONCLUSIONS: In children less than 10 years old, etomidate seems to produce minimal hemodynamic changes, and appears to have a low risk of clinically important adrenal insufficiency, myoclonus, and status epilepticus. The association between etomidate and emesis (observed in less than 3% of enrolled patients) remains unclear. For clinical situations in which minimal blood pressure changes during RSI are critical, etomidate appears to have a favorable risk-benefit profile for children under 10 years old. 相似文献
944.
一种双侧供肾大鼠肾移植模型的建立 总被引:5,自引:0,他引:5
目的 探讨同时取大鼠双侧肾脏分别移植的可行性,其目的是节省实验费用、缩短手术时间。方法 以近交系Brown-Norway大鼠为供者,同时取其双肾作为供肾,原位灌洗;近交系Lewis大鼠为受者,切除其左肾,移植供肾1只。以冠状动脉造影支架为支撑行供肾静脉与受者肾静脉端端吻合,供肾动脉与受者的腹主动脉行端侧吻合,供肾输尿管膀胱瓣与受者的膀胱吻合。受者术中预置右侧肾脏血管体外结扎线,术后3d结扎。结果 每只供鼠手术耗时约40min,热缺血时间约10S,冷缺血时间约20min。40次实验均获成功,移植肾功能正常,在不用免疫抑制剂的情况下,受者存活时间均超过7d。结论 同时取双侧肾脏分别移植给2个受者是可行的,可降低实验成本;要获得相同数量的供肾,同时取双肾的耗时较仅取单侧肾脏大大缩短。 相似文献
945.
Willemijn A K M Windt Atsua Tahara Alex C A Kluppel Dick de Zeeuw Robert H Henning Richard P E van Dokkum 《Journal of the renin-angiotensin-aldosterone system》2006,7(4):217-224
INTRODUCTION: Vasopressin, mainly through the V1a-receptor, is thought to be a major player in the maintenance of hyperfiltration. Its inhibition could therefore lead to a decrease in progression of chronic renal failure. To this end, the effect of the vasopressin V1a-receptor-selective antagonist, YM218, was studied on proteinuria and focal glomerulosclerosis in early and late intervention after 5/6 nephrectomy in rats, and compared with an angiotensin-converting enzyme inhibitor (ACE-I). MATERIALS AND METHODS: After 5/6 nephrectomy, early intervention was performed between week 2 and 10 thereafter with the V1a-receptor-selective antagonist (VRA, 10 mg/kg/day, n=10), enalapril (ACE-I, 10 mg/kg/day, n=9), or vehicle (n=8). Late intervention was performed in another group between week 6 and 12 with VRA (10 mg/kg/day, n=7), lisinopril (ACE-I, 5 mg/kg/day, n=7), or vehicle (n=7). RESULTS: In early intervention, proteinuria and focal glomerulosclerosis were significantly decreased by VRA compared to vehicle (44+7% and 59+8% respectively). ACE-I significantly decreased proteinuria (67+7%) and a trend towards a decrease in focal glomerulosclerosis was observed (30+18%). In late intervention, VRA did not decrease proteinuria and focal glomerulosclerosis compared to vehicle (21+20% and 0%, respectively), ACE-I significantly lowered proteinuria (92+2%) and a focal glomerulosclerosis (69+1%) lowering trend was observed. CONCLUSION: These results indicate that VRA may protect against early progression of renal injury after 5/6 nephrectomy, whereas its effectiveness seems limited in established renal damage. 相似文献
946.
947.
948.
949.
Robin L. Bissinger MSN RNC NNP Cheryl A. Carlson MS RNC NNP 《Newborn and Infant Nursing Reviews》2006,6(2):87
Surfactant, a complex substance containing specific proteins and phospholipids, is essential for gas exchange in the lungs. Research shows that surfactant not only lowers surface tension, but also plays a role in host defense. Surfactant replacement therapy is a cornerstone in the treatment of respiratory distress syndrome in premature infants. New information on endogenous surfactant composition including surfactant apoproteins has led to advances in the surfactant replacement products currently available. Because of the success of surfactant deficiency treatment in neonates, surfactant replacement therapy has been studied in both the pediatric and adult population for the treatment of other respiratory disorders. This article describes the composition, metabolism, and function of endogenous surfactant and other uses of surfactant replacement therapies in neonates. 相似文献
950.